Last reviewed · How we verify

NCT04577690

PECS Study for CIED Implantation Surgery

Status unknown Phase 4 Last updated 11 April 2023
What this trial tests

Phase 4 trial testing Bupivacaine 0.25% with epinephrine 1:200000 by PECS block and wound infiltration in Pain, Postoperative in 48 participants. Status unknown.

Timeline
1 December 2019
Primary endpoint
1 January 2024
1 January 2024

Quick facts

Lead sponsorThe Hospital for Sick Children
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment48
Start date1 December 2019
Primary completion1 January 2024
Estimated completion1 January 2024
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

The Hospital for Sick Children

Who can join

Adults 3 to 18, any sex, with Pain, Postoperative or Child. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We aim to determine whether pectoral nerve block (PECS) performed after induction of anesthesia but before surgical incision results less opioid use in the post operative period compared with local infiltration alone in children undergoing Cardiac Implantable Electronic Device (CIED) surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

Other The Hospital for Sick Children trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04577690.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing